Literature DB >> 27743708

Therapeutic plasma exchange in primary hemophagocytic lymphohistiocytosis: Reports of two cases and a review of the literature.

Mehmet Bosnak1, Seher Erdogan2, E Habibe Aktekin3, Ali Bay3.   

Abstract

We report two children who were diagnosed as having primary hemophagocytic syndrome and who successfully underwent therapeutic plasma exchange (TPE). The first patient was a 6-month-old girl diagnosed with HLH who was admitted to the pediatric intensive care unit. The patient's clinical condition worsened on the 9th day of the HLH-2004 treatment protocol. Her ferritin level was found 50.000 ng/mL, and TPE was performed for 9 sessions, after which her clinical condition and laboratory findings improved. The patient is still on the HLH-2004 protocol and waits for a suitable stem cell transplantation donor. Case 2 involved a Syrian girl with HLH under follow-up who was receiving the HLH-2004 treatment protocol for reactivation. She presented to emergency department with fever, where her ferritin level was measured greater than 100.000 ng/mL; she was then transferred to the pediatric intensive care unit where four sessions of TPE were performed, after which her clinical condition and laboratory findings improved. However, the patient was admitted again one month later with gastrointestinal bleeding and died despite all efforts. By describing these two cases, we wish to emphasize that TPE can produce a rapid improvement until the time of stem cell transplantation in patients with hemophagocytic syndrome who do not respond to traditional treatments.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammatory cytokine; Primary hemophagocytic syndrome; Therapeutic plasma exchange

Mesh:

Substances:

Year:  2016        PMID: 27743708     DOI: 10.1016/j.transci.2016.09.015

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  7 in total

1.  Efficacy of plasma exchange in children with severe hemophagocytic syndrome: a prospective randomized controlled trial.

Authors:  Yuan-Hong Yuan; Hui Zhang; Zheng-Hui Xiao; Xin-Ping Zhang; Xiu-Lan Lu; Zhi-Yue Xu; Jie He; Li-Feng Zhu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-03-15

Review 2.  Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis.

Authors:  Rebecca A Marsh
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

Review 3.  Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.

Authors:  Christian Zanza; Tatsiana Romenskaya; Alice Chiara Manetti; Francesco Franceschi; Raffaele La Russa; Giuseppe Bertozzi; Aniello Maiese; Gabriele Savioli; Gianpietro Volonnino; Yaroslava Longhitano
Journal:  Medicina (Kaunas)       Date:  2022-01-18       Impact factor: 2.430

Review 4.  Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature.

Authors:  Christian Nusshag; Christian Morath; Martin Zeier; Markus A Weigand; Uta Merle; Thorsten Brenner
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

5.  Hemophagocytic Syndrome-An Approach to the Management.

Authors:  Bindiya Salunke; Sukhada Savarkar; Vijaya Prakash Patil
Journal:  Indian J Crit Care Med       Date:  2019-09

6.  Hemophagocytic Lymphohistiocytosis Related to Tuberculosis Disease.

Authors:  Seher Erdoğan; Deniz Çakır; Tuğçe Bozkurt; Burcu Karakayalı; Sevinç Kalın; Begüm Koç; Betül Sözeri
Journal:  Indian J Crit Care Med       Date:  2020-01

7.  Effectiveness of therapeutic plasma exchange in a critically ill child with secondary hemophagocytic lymphohistiocytosis.

Authors:  Prashant Kumar Pandey; Esha Kaul; Nitin Agarwal; Shalendra Goel
Journal:  Asian J Transfus Sci       Date:  2019-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.